APO Research
Talk to an analyst

APO RESEARCH · REPORT

Quetiapine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Quetiapine Market Outlook and Growth Opportunities 2026

23 December 2025206 pages

Choose your research edition.

Industry ResearchQuetiapine Industry Research Report 2026149 pages · $2,950 USDIndustry Growth & TrendsGlobal Quetiapine Industry Growth and Trends Forecast to 2032126 pages · $3,450 USDMarket StructureGlobal Quetiapine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Quetiapine Market Outlook and Growth Opportunities 2026206 pages · $4,250 USDMarket Analysis & ForecastGlobal Quetiapine Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Quetiapine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Quetiapine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Quetiapine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Quetiapine market include XiaoGan ShenYuan ChemPharm, Teva, Sun Pharmaceutical, Sandoz, Qilu Pharmaceutical, Nanjing Sunlida Biological Technology, Mylan, Lupin and Hetero, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Quetiapine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Quetiapine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Quetiapine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Quetiapine market size, projected growth trends, production technologies, key applications, and end-use industries.

Quetiapine Segment by Company

XiaoGan ShenYuan ChemPharm

Teva

Sun Pharmaceutical

Sandoz

Qilu Pharmaceutical

Nanjing Sunlida Biological Technology

Mylan

Lupin

Hetero

Shanghai Haoyuan Chemexpress

Dr. Reddy's

Aurobindo

AstraZeneca

Wuhan Fortuna Chemical

Waterstone Technology

Toronto Research Chemicals

Nanjing Chemlin Chemical

EMMX Biotechnology

BOC Sciences

AlliChem

Quetiapine Segment by Type

Purity 97%

Purity 98%

Others

Quetiapine Segment by Application

Adult

Aged

Quetiapine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Quetiapine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Quetiapine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Quetiapine significant trends, drivers, influence factors in global and regions.

6. To analyze Quetiapine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Quetiapine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Quetiapine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Quetiapine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Quetiapine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Quetiapine industry.

Chapter 3: Detailed analysis of Quetiapine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Quetiapine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Quetiapine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Quetiapine Industry Trends Table 2. Quetiapine Industry Drivers Table 3. Quetiapine Industry Opportunities and Challenges Table 4. Quetiapine Industry Restraints Table 5. Global Quetiapine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Quetiapine Revenue Share by Company (2021-2026) Table 7. Global Quetiapine Sales Volume by Company (kg) & (2021-2026) Table 8. Global Quetiapine Sales Volume Share by Company (2021-2026) Table 9. Global Quetiapine Average Price (USD/kg) of Company (2021-2026) Table 10. Global Quetiapine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Quetiapine Key Company Manufacturing Base & Headquarters Table 12. Global Quetiapine Company, Product Type & Application Table 13. Global Quetiapine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Quetiapine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity 97% Table 18. Significant Companies of Purity 98% Table 19. Significant Companies of Others Table 20. Global Quetiapine Sales Volume by Type 2021 VS 2025 VS 2032 (kg) Table 21. Global Quetiapine Sales Volume by Type (2021-2026) & (kg) Table 22. Global Quetiapine Sales Volume by Type (2027-2032) & (kg) Table 23. Global Quetiapine Sales Volume Share by Type (2021-2026) Table 24. Global Quetiapine Sales Volume Share by Type (2027-2032) Table 25. Global Quetiapine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Quetiapine Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Quetiapine Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Quetiapine Sales Value Share by Type (2021-2026) Table 29. Global Quetiapine Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Adult Table 31. Significant Companies of Aged Table 32. Global Quetiapine Sales Volume by Application 2021 VS 2025 VS 2032 (kg) Table 33. Global Quetiapine Sales Volume by Application (2021-2026) & (kg) Table 34. Global Quetiapine Sales Volume by Application (2027-2032) & (kg) Table 35. Global Quetiapine Sales Volume Share by Application (2021-2026) Table 36. Global Quetiapine Sales Volume Share by Application (2027-2032) Table 37. Global Quetiapine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Quetiapine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Quetiapine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Quetiapine Sales Value Share by Application (2021-2026) Table 41. Global Quetiapine Sales Value Share by Application (2027-2032) Table 42. Global Quetiapine Sales by Region: 2021 VS 2025 VS 2032 (kg) Table 43. Global Quetiapine Sales by Region (2021-2026) & (kg) Table 44. Global Quetiapine Sales Market Share by Region (2021-2026) Table 45. Global Quetiapine Sales by Region (2027-2032) & (kg) Table 46. Global Quetiapine Sales Market Share by Region (2027-2032) Table 47. Global Quetiapine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Quetiapine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Quetiapine Sales Value Share by Region (2021-2026) Table 50. Global Quetiapine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Quetiapine Sales Value Share by Region (2027-2032) Table 52. Global Quetiapine Market Average Price (USD/kg) by Region (2021-2026) Table 53. Global Quetiapine Market Average Price (USD/kg) by Region (2027-2032) Table 54. Global Quetiapine Sales by Country: 2021 VS 2025 VS 2032 (kg) Table 55. Global Quetiapine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Quetiapine Sales by Country (2021-2026) & (kg) Table 57. Global Quetiapine Sales Market Share by Country (2021-2026) Table 58. Global Quetiapine Sales by Country (2027-2032) & (kg) Table 59. Global Quetiapine Sales Market Share by Country (2027-2032) Table 60. Global Quetiapine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Quetiapine Sales Value Market Share by Country (2021-2026) Table 62. Global Quetiapine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Quetiapine Sales Value Market Share by Country (2027-2032) Table 64. XiaoGan ShenYuan ChemPharm Company Information Table 65. XiaoGan ShenYuan ChemPharm Business Overview Table 66. XiaoGan ShenYuan ChemPharm Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 67. XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio Table 68. XiaoGan ShenYuan ChemPharm Recent Development Table 69. Teva Company Information Table 70. Teva Business Overview Table 71. Teva Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 72. Teva Quetiapine Product Portfolio Table 73. Teva Recent Development Table 74. Sun Pharmaceutical Company Information Table 75. Sun Pharmaceutical Business Overview Table 76. Sun Pharmaceutical Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 77. Sun Pharmaceutical Quetiapine Product Portfolio Table 78. Sun Pharmaceutical Recent Development Table 79. Sandoz Company Information Table 80. Sandoz Business Overview Table 81. Sandoz Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 82. Sandoz Quetiapine Product Portfolio Table 83. Sandoz Recent Development Table 84. Qilu Pharmaceutical Company Information Table 85. Qilu Pharmaceutical Business Overview Table 86. Qilu Pharmaceutical Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 87. Qilu Pharmaceutical Quetiapine Product Portfolio Table 88. Qilu Pharmaceutical Recent Development Table 89. Nanjing Sunlida Biological Technology Company Information Table 90. Nanjing Sunlida Biological Technology Business Overview Table 91. Nanjing Sunlida Biological Technology Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 92. Nanjing Sunlida Biological Technology Quetiapine Product Portfolio Table 93. Nanjing Sunlida Biological Technology Recent Development Table 94. Mylan Company Information Table 95. Mylan Business Overview Table 96. Mylan Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 97. Mylan Quetiapine Product Portfolio Table 98. Mylan Recent Development Table 99. Lupin Company Information Table 100. Lupin Business Overview Table 101. Lupin Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 102. Lupin Quetiapine Product Portfolio Table 103. Lupin Recent Development Table 104. Hetero Company Information Table 105. Hetero Business Overview Table 106. Hetero Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 107. Hetero Quetiapine Product Portfolio Table 108. Hetero Recent Development Table 109. Shanghai Haoyuan Chemexpress Company Information Table 110. Shanghai Haoyuan Chemexpress Business Overview Table 111. Shanghai Haoyuan Chemexpress Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 112. Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio Table 113. Shanghai Haoyuan Chemexpress Recent Development Table 114. Dr. Reddy's Company Information Table 115. Dr. Reddy's Business Overview Table 116. Dr. Reddy's Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 117. Dr. Reddy's Quetiapine Product Portfolio Table 118. Dr. Reddy's Recent Development Table 119. Aurobindo Company Information Table 120. Aurobindo Business Overview Table 121. Aurobindo Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 122. Aurobindo Quetiapine Product Portfolio Table 123. Aurobindo Recent Development Table 124. AstraZeneca Company Information Table 125. AstraZeneca Business Overview Table 126. AstraZeneca Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 127. AstraZeneca Quetiapine Product Portfolio Table 128. AstraZeneca Recent Development Table 129. Wuhan Fortuna Chemical Company Information Table 130. Wuhan Fortuna Chemical Business Overview Table 131. Wuhan Fortuna Chemical Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 132. Wuhan Fortuna Chemical Quetiapine Product Portfolio Table 133. Wuhan Fortuna Chemical Recent Development Table 134. Waterstone Technology Company Information Table 135. Waterstone Technology Business Overview Table 136. Waterstone Technology Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 137. Waterstone Technology Quetiapine Product Portfolio Table 138. Waterstone Technology Recent Development Table 139. Toronto Research Chemicals Company Information Table 140. Toronto Research Chemicals Business Overview Table 141. Toronto Research Chemicals Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 142. Toronto Research Chemicals Quetiapine Product Portfolio Table 143. Toronto Research Chemicals Recent Development Table 144. Nanjing Chemlin Chemical Company Information Table 145. Nanjing Chemlin Chemical Business Overview Table 146. Nanjing Chemlin Chemical Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 147. Nanjing Chemlin Chemical Quetiapine Product Portfolio Table 148. Nanjing Chemlin Chemical Recent Development Table 149. EMMX Biotechnology Company Information Table 150. EMMX Biotechnology Business Overview Table 151. EMMX Biotechnology Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 152. EMMX Biotechnology Quetiapine Product Portfolio Table 153. EMMX Biotechnology Recent Development Table 154. BOC Sciences Company Information Table 155. BOC Sciences Business Overview Table 156. BOC Sciences Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 157. BOC Sciences Quetiapine Product Portfolio Table 158. BOC Sciences Recent Development Table 159. AlliChem Company Information Table 160. AlliChem Business Overview Table 161. AlliChem Quetiapine Sales (kg), Value (US$ Million), Price (USD/kg) and Gross Margin (2021-2026) Table 162. AlliChem Quetiapine Product Portfolio Table 163. AlliChem Recent Development Table 164. Key Raw Materials Table 165. Raw Materials Key Suppliers Table 166. Quetiapine Distributors List Table 167. Quetiapine Customers List Table 168. Research Programs/Design for This Report Table 169. Authors List of This Report Table 170. Secondary Sources Table 171. Primary Sources List of Figures Figure 1. Quetiapine Product Image Figure 2. Global Quetiapine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Quetiapine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Quetiapine Sales (2021-2032) & (kg) Figure 5. Global Quetiapine Sales Average Price (USD/kg) & (2021-2032) Figure 6. Global Quetiapine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity 97% Image Figure 10. Purity 98% Image Figure 11. Others Image Figure 12. Global Quetiapine Sales Volume by Type (2021 VS 2025 VS 2032) & (kg) Figure 13. Global Quetiapine Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Quetiapine Sales Volume Share by Type (2021-2032) Figure 15. Global Quetiapine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Quetiapine Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Quetiapine Sales Value Share by Type (2021-2032) Figure 18. Adult Image Figure 19. Aged Image Figure 20. Global Quetiapine Sales Volume by Application (2021 VS 2025 VS 2032) & (kg) Figure 21. Global Quetiapine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Quetiapine Sales Volume Share by Application (2021-2032) Figure 23. Global Quetiapine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Quetiapine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Quetiapine Sales Value Share by Application (2021-2032) Figure 26. Global Quetiapine Sales by Region: 2021 VS 2025 VS 2032 (kg) Figure 27. Global Quetiapine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Quetiapine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Quetiapine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Quetiapine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Quetiapine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Quetiapine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Quetiapine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Quetiapine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Quetiapine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Quetiapine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Quetiapine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Quetiapine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Quetiapine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Quetiapine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Quetiapine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Quetiapine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Quetiapine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Quetiapine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Purity 97%
  • Purity 98%
  • Others
Applications
  • Adult
  • Aged
Companies covered
  • XiaoGan ShenYuan ChemPharm
  • Teva
  • Sun Pharmaceutical
  • Sandoz
  • Qilu Pharmaceutical
  • Nanjing Sunlida Biological Technology
  • Mylan
  • Lupin
  • Hetero
  • Shanghai Haoyuan Chemexpress
  • Dr. Reddy's
  • Aurobindo
  • AstraZeneca
  • Wuhan Fortuna Chemical
  • Waterstone Technology
  • Toronto Research Chemicals
  • Nanjing Chemlin Chemical
  • EMMX Biotechnology
  • BOC Sciences
  • AlliChem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Quetiapine Sales Value (2021-2032)
  4. 1.2.2 Global Quetiapine Sales Volume (2021-2032)
  5. 1.2.3 Global Quetiapine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Quetiapine Market Dynamics
  1. 2.1 Quetiapine Industry Trends
  2. 2.2 Quetiapine Industry Drivers
  3. 2.3 Quetiapine Industry Opportunities and Challenges
  4. 2.4 Quetiapine Industry Restraints
3 Quetiapine Market by Company
  1. 3.1 Global Quetiapine Company Revenue Ranking in 2025
  2. 3.2 Global Quetiapine Revenue by Company (2021-2026)
  3. 3.3 Global Quetiapine Sales Volume by Company (2021-2026)
  4. 3.4 Global Quetiapine Average Price by Company (2021-2026)
  5. 3.5 Global Quetiapine Company Ranking (2024-2026)
  6. 3.6 Global Quetiapine Company Manufacturing Base and Headquarters
  7. 3.7 Global Quetiapine Company Product Type and Application
  8. 3.8 Global Quetiapine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Quetiapine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Quetiapine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Quetiapine Market by Type
  1. 4.1 Quetiapine Type Introduction
  2. 4.1.1 Purity 97%
  3. 4.1.2 Purity 98%
  4. 4.1.3 Others
  5. 4.2 Global Quetiapine Sales Volume by Type
  6. 4.2.1 Global Quetiapine Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Quetiapine Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Quetiapine Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Quetiapine Sales Value by Type
  10. 4.3.1 Global Quetiapine Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Quetiapine Sales Value by Type (2021-2032)
  12. 4.3.3 Global Quetiapine Sales Value Share by Type (2021-2032)
5 Quetiapine Market by Application
  1. 5.1 Quetiapine Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Aged
  4. 5.2 Global Quetiapine Sales Volume by Application
  5. 5.2.1 Global Quetiapine Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Quetiapine Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Quetiapine Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Quetiapine Sales Value by Application
  9. 5.3.1 Global Quetiapine Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Quetiapine Sales Value by Application (2021-2032)
  11. 5.3.3 Global Quetiapine Sales Value Share by Application (2021-2032)
6 Quetiapine Regional Sales and Value Analysis
  1. 6.1 Global Quetiapine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Quetiapine Sales by Region (2021-2032)
  3. 6.2.1 Global Quetiapine Sales by Region: 2021-2026
  4. 6.2.2 Global Quetiapine Sales by Region (2027-2032)
  5. 6.3 Global Quetiapine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Quetiapine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Quetiapine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Quetiapine Sales Value by Region (2027-2032)
  9. 6.5 Global Quetiapine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Quetiapine Sales Value (2021-2032)
  12. 6.6.2 North America Quetiapine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Quetiapine Sales Value (2021-2032)
  15. 6.7.2 Europe Quetiapine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Quetiapine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Quetiapine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Quetiapine Sales Value (2021-2032)
  21. 6.9.2 South America Quetiapine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Quetiapine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Quetiapine Sales Value Share by Country, 2025 VS 2032
7 Quetiapine Country-level Sales and Value Analysis
  1. 7.1 Global Quetiapine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Quetiapine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Quetiapine Sales by Country (2021-2032)
  4. 7.3.1 Global Quetiapine Sales by Country (2021-2026)
  5. 7.3.2 Global Quetiapine Sales by Country (2027-2032)
  6. 7.4 Global Quetiapine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Quetiapine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Quetiapine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Quetiapine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Quetiapine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Quetiapine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Quetiapine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Quetiapine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Quetiapine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Quetiapine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Quetiapine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Quetiapine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Quetiapine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Quetiapine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Quetiapine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Quetiapine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Quetiapine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Quetiapine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Quetiapine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Quetiapine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Quetiapine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Quetiapine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Quetiapine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Quetiapine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Quetiapine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Quetiapine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Quetiapine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Quetiapine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Quetiapine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Quetiapine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Quetiapine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Quetiapine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Quetiapine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Quetiapine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Quetiapine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Quetiapine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Quetiapine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Quetiapine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Quetiapine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Quetiapine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Quetiapine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Quetiapine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Quetiapine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Quetiapine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Quetiapine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Quetiapine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Quetiapine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Quetiapine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Quetiapine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Quetiapine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Quetiapine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Quetiapine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Quetiapine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Quetiapine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Quetiapine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Quetiapine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Quetiapine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Quetiapine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Quetiapine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Quetiapine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Quetiapine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Quetiapine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Quetiapine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Quetiapine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Quetiapine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Quetiapine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Quetiapine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Quetiapine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Quetiapine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Quetiapine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Quetiapine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Quetiapine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Quetiapine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Quetiapine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Quetiapine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Quetiapine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Quetiapine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Quetiapine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Quetiapine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Quetiapine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Quetiapine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Quetiapine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Quetiapine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Quetiapine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Quetiapine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Quetiapine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Quetiapine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 XiaoGan ShenYuan ChemPharm
  2. 8.1.1 XiaoGan ShenYuan ChemPharm Company Information
  3. 8.1.2 XiaoGan ShenYuan ChemPharm Business Overview
  4. 8.1.3 XiaoGan ShenYuan ChemPharm Quetiapine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 XiaoGan ShenYuan ChemPharm Quetiapine Product Portfolio
  6. 8.1.5 XiaoGan ShenYuan ChemPharm Recent Developments
  7. 8.2 Teva
  8. 8.2.1 Teva Company Information
  9. 8.2.2 Teva Business Overview
  10. 8.2.3 Teva Quetiapine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Teva Quetiapine Product Portfolio
  12. 8.2.5 Teva Recent Developments
  13. 8.3 Sun Pharmaceutical
  14. 8.3.1 Sun Pharmaceutical Company Information
  15. 8.3.2 Sun Pharmaceutical Business Overview
  16. 8.3.3 Sun Pharmaceutical Quetiapine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Sun Pharmaceutical Quetiapine Product Portfolio
  18. 8.3.5 Sun Pharmaceutical Recent Developments
  19. 8.4 Sandoz
  20. 8.4.1 Sandoz Company Information
  21. 8.4.2 Sandoz Business Overview
  22. 8.4.3 Sandoz Quetiapine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Sandoz Quetiapine Product Portfolio
  24. 8.4.5 Sandoz Recent Developments
  25. 8.5 Qilu Pharmaceutical
  26. 8.5.1 Qilu Pharmaceutical Company Information
  27. 8.5.2 Qilu Pharmaceutical Business Overview
  28. 8.5.3 Qilu Pharmaceutical Quetiapine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Qilu Pharmaceutical Quetiapine Product Portfolio
  30. 8.5.5 Qilu Pharmaceutical Recent Developments
  31. 8.6 Nanjing Sunlida Biological Technology
  32. 8.6.1 Nanjing Sunlida Biological Technology Company Information
  33. 8.6.2 Nanjing Sunlida Biological Technology Business Overview
  34. 8.6.3 Nanjing Sunlida Biological Technology Quetiapine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Nanjing Sunlida Biological Technology Quetiapine Product Portfolio
  36. 8.6.5 Nanjing Sunlida Biological Technology Recent Developments
  37. 8.7 Mylan
  38. 8.7.1 Mylan Company Information
  39. 8.7.2 Mylan Business Overview
  40. 8.7.3 Mylan Quetiapine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Mylan Quetiapine Product Portfolio
  42. 8.7.5 Mylan Recent Developments
  43. 8.8 Lupin
  44. 8.8.1 Lupin Company Information
  45. 8.8.2 Lupin Business Overview
  46. 8.8.3 Lupin Quetiapine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Lupin Quetiapine Product Portfolio
  48. 8.8.5 Lupin Recent Developments
  49. 8.9 Hetero
  50. 8.9.1 Hetero Company Information
  51. 8.9.2 Hetero Business Overview
  52. 8.9.3 Hetero Quetiapine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Hetero Quetiapine Product Portfolio
  54. 8.9.5 Hetero Recent Developments
  55. 8.10 Shanghai Haoyuan Chemexpress
  56. 8.10.1 Shanghai Haoyuan Chemexpress Company Information
  57. 8.10.2 Shanghai Haoyuan Chemexpress Business Overview
  58. 8.10.3 Shanghai Haoyuan Chemexpress Quetiapine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Shanghai Haoyuan Chemexpress Quetiapine Product Portfolio
  60. 8.10.5 Shanghai Haoyuan Chemexpress Recent Developments
  61. 8.11 Dr. Reddy's
  62. 8.11.1 Dr. Reddy's Company Information
  63. 8.11.2 Dr. Reddy's Business Overview
  64. 8.11.3 Dr. Reddy's Quetiapine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Dr. Reddy's Quetiapine Product Portfolio
  66. 8.11.5 Dr. Reddy's Recent Developments
  67. 8.12 Aurobindo
  68. 8.12.1 Aurobindo Company Information
  69. 8.12.2 Aurobindo Business Overview
  70. 8.12.3 Aurobindo Quetiapine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Aurobindo Quetiapine Product Portfolio
  72. 8.12.5 Aurobindo Recent Developments
  73. 8.13 AstraZeneca
  74. 8.13.1 AstraZeneca Company Information
  75. 8.13.2 AstraZeneca Business Overview
  76. 8.13.3 AstraZeneca Quetiapine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 AstraZeneca Quetiapine Product Portfolio
  78. 8.13.5 AstraZeneca Recent Developments
  79. 8.14 Wuhan Fortuna Chemical
  80. 8.14.1 Wuhan Fortuna Chemical Company Information
  81. 8.14.2 Wuhan Fortuna Chemical Business Overview
  82. 8.14.3 Wuhan Fortuna Chemical Quetiapine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Wuhan Fortuna Chemical Quetiapine Product Portfolio
  84. 8.14.5 Wuhan Fortuna Chemical Recent Developments
  85. 8.15 Waterstone Technology
  86. 8.15.1 Waterstone Technology Company Information
  87. 8.15.2 Waterstone Technology Business Overview
  88. 8.15.3 Waterstone Technology Quetiapine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Waterstone Technology Quetiapine Product Portfolio
  90. 8.15.5 Waterstone Technology Recent Developments
  91. 8.16 Toronto Research Chemicals
  92. 8.16.1 Toronto Research Chemicals Company Information
  93. 8.16.2 Toronto Research Chemicals Business Overview
  94. 8.16.3 Toronto Research Chemicals Quetiapine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Toronto Research Chemicals Quetiapine Product Portfolio
  96. 8.16.5 Toronto Research Chemicals Recent Developments
  97. 8.17 Nanjing Chemlin Chemical
  98. 8.17.1 Nanjing Chemlin Chemical Company Information
  99. 8.17.2 Nanjing Chemlin Chemical Business Overview
  100. 8.17.3 Nanjing Chemlin Chemical Quetiapine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Nanjing Chemlin Chemical Quetiapine Product Portfolio
  102. 8.17.5 Nanjing Chemlin Chemical Recent Developments
  103. 8.18 EMMX Biotechnology
  104. 8.18.1 EMMX Biotechnology Company Information
  105. 8.18.2 EMMX Biotechnology Business Overview
  106. 8.18.3 EMMX Biotechnology Quetiapine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 EMMX Biotechnology Quetiapine Product Portfolio
  108. 8.18.5 EMMX Biotechnology Recent Developments
  109. 8.19 BOC Sciences
  110. 8.19.1 BOC Sciences Company Information
  111. 8.19.2 BOC Sciences Business Overview
  112. 8.19.3 BOC Sciences Quetiapine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 BOC Sciences Quetiapine Product Portfolio
  114. 8.19.5 BOC Sciences Recent Developments
  115. 8.20 AlliChem
  116. 8.20.1 AlliChem Company Information
  117. 8.20.2 AlliChem Business Overview
  118. 8.20.3 AlliChem Quetiapine Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 AlliChem Quetiapine Product Portfolio
  120. 8.20.5 AlliChem Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Quetiapine Value Chain Analysis
  2. 9.1.1 Quetiapine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Quetiapine Sales Mode & Process
  6. 9.2 Quetiapine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Quetiapine Distributors
  9. 9.2.3 Quetiapine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst